NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fund+

Fund+

Leuven, Flandersfundplus.be

Overview

Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. It aims to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.

Year Founded

2015

Portfolio Companies

16

Investments

Fund+ investments
CompanyDateStageLead
TargED BiopharmaceuticalsJun 2026Series A ExtensionCo-investor
Ona TherapeuticsJun 2026Series BCo-investor
TubulisOct 2025Series CCo-investor
EPICS TherapeuticsSep 2025VC RoundCo-investor
Coave TherapeuticsJan 2025Series ACo-investor

Key People

Caroline Goddeeris

Venture Partner

Halina Novak

Associate Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLeuven, Flanders
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.